Study on the Diagnosis and Management of CLL in Italy by GIMEMA

ConditionsChronic Lymphocytic Leukemia Small Lymphocytic Lymphoma MBL-CLL - Monoclonal B-Cell Lymphocytosis Chronic Lymphocytic Leukaemia-Type

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorGruppo Italiano Malattie EMatologiche dell'Adulto

About this trial

retrospective and prospective multicenter observational clinical and biological data collection from all patients with newly diagnosed CLL, SLL or MBL.

retrospective cohort: all cases with a diagnosis between January 1st 2010 and August 31th 2021.

prospective cohort: all patients with a diagnosis between September 1st 2021 and September 1st 2025.

Eligibility criteria

Qualifiers

Age ≥18 years at diagnosis

One of the following diagnoses that meet the international diagnostic criteria (iwCLL2018 and WHO2017)

Chronic lymphocytic leukemia (CLL)

Small lymphocytic lymphoma (SLL)

Disqualifiers

- -

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Locations24

Select a site below to view it on the map.

Sponsors and collaborators

Gruppo Italiano Malattie EMatologiche dell'Adulto

Lead sponsor

Source ClinicalTrials.gov